John B. Payne - Jun 5, 2024 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZIVO	Nonstatutory Stock Option to Purchase Common Stock	Disposed to Issuer		-1.9K	-100%		0	Jun 5, 2024	Common Stock	1.9K	$26.88	Direct	F1, F2, F3
transaction	ZIVO	Nonstatutory Stock Option to Purchase Common Stock	Disposed to Issuer		-32K	-100%		0	Jun 5, 2024	Common Stock	32K	$33.00	Direct	F1, F2, F3
transaction	ZIVO	Nonstatutory Stock Option to Purchase Common Stock	Disposed to Issuer		-31.8K	-100%		0	Jun 5, 2024	Common Stock	31.8K	$17.16	Direct	F1, F2, F3
transaction	ZIVO	Nonstatutory Stock Option to Purchase Common Stock	Award		+167K			167K	Jun 5, 2024	Common Stock	167K	$7.96	Direct	F3, F4
transaction	ZIVO	Nonstatutory Stock Option to Purchase Common Stock	Award	$0	+50.3K		$0.00	50.3K	Jun 5, 2024	Common Stock	50.3K	$7.96	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
F2	The canceled options were fully vested.
F3	The Issuer canceled options for an aggregate 65,738 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, and 12/16/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 167,180 shares, having an exercise price of $7.96.
F4	The option was issued pursuant to the 2021 Equity Incentive Plan and all options vested immediately upon the date of acceptance of grant.